Table 1.
Clinicopathological characteristics of 212 patients with bladder cancer undergoing transurethral resection of the bladder tumor stratified by DAB2 expression level in the cancerous area.
| Number of Patients (%) |
DAB2 Expression | p-Value † | |||
|---|---|---|---|---|---|
| Low | High | ||||
| Total | 212 | 116 | 96 | ||
| Age, years, median (range) | 71 (34–94) | 70 (34–94) | 71 (41–93) | 0.64 | |
| Gender | Male | 181 (86.8) | 86 | 95 | 0.19 |
| Female | 28 (13.2) | 17 | 11 | ||
| clinical T stage | Ta | 68 (32.1) | 48 | 20 | 0.014 |
| T1 | 81 (38.2) | 39 | 42 | ||
| Tis | 13 (6.1) | 5 | 8 | ||
| ≥T2 | 50 (23.6) | 24 | 26 | ||
| Grade | Low | 71 (33.5) | 55 | 16 | <0.001 |
| High | 141 (66.5) | 61 | 80 | ||
| Carcinoma in situ | Negative | 137 (64.6) | 91 | 46 | <0.001 |
| Positive | 75 (35.4) | 25 | 50 | ||
| Lymphovascular invasion (≥T1) |
Negative | 65 (49.6) | 37 | 28 | 0.045 |
| Positive | 66 (50.4) | 26 | 40 | ||
| Histological variants | Yes | 33 (15.6) | 11 | 22 | <0.01 |
| No | 179 (84.4) | 105 | 74 | ||
| Lymph node status | N0 | 207 (97.6) | 114 | 93 | 0.83 |
| N1, N2 | 5 (2.3) | 2 | 3 | ||
| Tumor size | ≤3 cm | 150 (70.8) | 85 | 65 | 0.38 |
| >3 cm | 62 (29.2) | 31 | 31 | ||
| Number of tumor | single | 122 (57.5) | 70 | 52 | 0.36 |
| ≥2 | 90 (42.5) | 46 | 44 | ||
| Infiltration pattern (INF) | a | 86 (40.6) | 57 | 30 | 0.028 |
| b | 83 (39.2) | 40 | 42 | ||
| c | 43 (20.2) | 19 | 24 | ||
† comparing age uging t test and other two groups using the Chi square test.